CARDIOVASCULAR RISK PROFILE OF RENAL TRANSPLANT RECIPIENTS ENROLLED IN AN OPEN LABEL, RANDOMIZED STUDY COMPARING 2 SIROLIMUS (SRL) REGIMENS WITH A TACROLIMUS (TAC) + MYCOPHENOLATE REGIMEN (MMF): PRELIMINARY RESULTS FROM THE ORION TRIAL | Publicación